Last update 08 Dec 2025

177Lu-LNC1009

Overview

Basic Info

Drug Type
Radionuclide Drug Conjugates (RDC), Therapeutic radiopharmaceuticals
Synonyms
177Lu-LNC1009
Target
FAP x αvβ3
Action
antagonists
Mechanism
FAP antagonists(Fibroblast activation protein alpha antagonists), αvβ3 antagonists(Integrin alpha-V/beta-3 antagonists)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmSolid tumor
Inactive Indication-
Originator Organization
Yantai Lannacheng Biotechnology Co., Ltd.Yantai Lannacheng Biotechnology Co., Ltd.
Active Organization
Yantai Lannacheng Biotechnology Co., Ltd.Yantai Lannacheng Biotechnology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

100 Clinical Results associated with 177Lu-LNC1009
Login to view more data
100 Translational Medicine associated with 177Lu-LNC1009
Login to view more data
100 Patents (Medical) associated with 177Lu-LNC1009
Login to view more data
100 Deals associated with 177Lu-LNC1009
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmIND Approval
China
Yantai Lannacheng Biotechnology Co., Ltd.Yantai Lannacheng Biotechnology Co., Ltd.
08 Dec 2025
Solid tumorPreclinical
Global
Yantai Lannacheng Biotechnology Co., Ltd.Yantai Lannacheng Biotechnology Co., Ltd.
25 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free